BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 16835078)

  • 1. How valid is single nucleotide polymorphism (SNP) diagnosis for the individual risk assessment of breast cancer?
    Tempfer CB; Hefler LA; Schneeberger C; Huber JC
    Gynecol Endocrinol; 2006 Mar; 22(3):155-9. PubMed ID: 16835078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vitamin D pathway gene polymorphisms, diet, and risk of postmenopausal breast cancer: a nested case-control study.
    McCullough ML; Stevens VL; Diver WR; Feigelson HS; Rodriguez C; Bostick RM; Thun MJ; Calle EE
    Breast Cancer Res; 2007; 9(1):R9. PubMed ID: 17244366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic polymorphisms in the DNA repair genes XRCC1, XRCC2 and XRCC3 and risk of breast cancer in Cyprus.
    Loizidou MA; Michael T; Neuhausen SL; Newbold RF; Marcou Y; Kakouri E; Daniel M; Papadopoulos P; Malas S; Kyriacou K; Hadjisavvas A
    Breast Cancer Res Treat; 2008 Dec; 112(3):575-9. PubMed ID: 18188695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Large-scale evaluation of genetic variants in candidate genes for colorectal cancer risk in the Nurses' Health Study and the Health Professionals' Follow-up Study.
    Hazra A; Chanock S; Giovannucci E; Cox DG; Niu T; Fuchs C; Willett WC; Hunter DJ
    Cancer Epidemiol Biomarkers Prev; 2008 Feb; 17(2):311-9. PubMed ID: 18268114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymorphisms in nonhomologous end-joining genes associated with breast cancer risk and chromosomal radiosensitivity.
    Willems P; Claes K; Baeyens A; Vandersickel V; Werbrouck J; De Ruyck K; Poppe B; Van den Broecke R; Makar A; Marras E; Perletti G; Thierens H; Vral A
    Genes Chromosomes Cancer; 2008 Feb; 47(2):137-48. PubMed ID: 18000863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Applications of polymorphisms and pharmacogenomics in obstetrics and gynecology.
    Tempfer CB; Schneeberger C; Huber JC
    Pharmacogenomics; 2004 Jan; 5(1):57-65. PubMed ID: 14683420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fok1 polymorphism of vitamin D receptor gene contributes to breast cancer susceptibility: a meta-analysis.
    Tang C; Chen N; Wu M; Yuan H; Du Y
    Breast Cancer Res Treat; 2009 Sep; 117(2):391-9. PubMed ID: 19145484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic variation in TP53 and risk of breast cancer in a population-based case control study.
    Sprague BL; Trentham-Dietz A; Garcia-Closas M; Newcomb PA; Titus-Ernstoff L; Hampton JM; Chanock SJ; Haines JL; Egan KM
    Carcinogenesis; 2007 Aug; 28(8):1680-6. PubMed ID: 17449902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutation analysis and characterization of ATR sequence variants in breast cancer cases from high-risk French Canadian breast/ovarian cancer families.
    Durocher F; Labrie Y; Soucy P; Sinilnikova O; Labuda D; Bessette P; Chiquette J; Laframboise R; Lépine J; Lespérance B; Ouellette G; Pichette R; Plante M; Tavtigian SV; Simard J
    BMC Cancer; 2006 Sep; 6():230. PubMed ID: 17010193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single nucleotide polymorphisms in the hypoxia-inducible factor-1alpha (HIF-1alpha) gene in human sporadic breast cancer.
    Apaydin I; Konac E; Onen HI; Akbaba M; Tekin E; Ekmekci A
    Arch Med Res; 2008 Apr; 39(3):338-45. PubMed ID: 18279708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitamin D receptor polymorphisms and breast cancer risk: results from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium.
    McKay JD; McCullough ML; Ziegler RG; Kraft P; Saltzman BS; Riboli E; Barricarte A; Berg CD; Bergland G; Bingham S; Brustad M; Bueno-de-Mesquita HB; Burdette L; Buring J; Calle EE; Chanock SJ; Clavel-Chapelon F; Cox DG; Dossus L; Feigelson HS; Haiman CA; Hankinson SE; Hoover RN; Hunter DJ; Husing A; Kaaks R; Kolonel LN; Le Marchand L; Linseisen J; McCarty CA; Overvad K; Panico S; Purdue MP; Stram DO; Stevens VL; Trichopoulos D; Willett WC; Yuenger J; Thun MJ
    Cancer Epidemiol Biomarkers Prev; 2009 Jan; 18(1):297-305. PubMed ID: 19124512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluating new candidate SNPs as low penetrance risk factors in sporadic breast cancer: a two-stage Spanish case-control study.
    Vega A; Salas A; Milne RL; Carracedo B; Ribas G; Ruibal A; de León AC; González-Hernández A; Benítez J; Carracedo A
    Gynecol Oncol; 2009 Jan; 112(1):210-4. PubMed ID: 18950845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Associations between androgen and Vitamin D receptor microsatellites and postmenopausal breast cancer.
    Wedrén S; Magnusson C; Humphreys K; Melhus H; Kindmark A; Stiger F; Branting M; Persson I; Baron J; Weiderpass E
    Cancer Epidemiol Biomarkers Prev; 2007 Sep; 16(9):1775-83. PubMed ID: 17855696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of expression data and the CGEMS genome-wide breast cancer association study to identify genes that may modify risk in BRCA1/2 mutation carriers.
    Walker LC; Waddell N; Ten Haaf A; ; Grimmond S; Spurdle AB
    Breast Cancer Res Treat; 2008 Nov; 112(2):229-36. PubMed ID: 18095154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Age-specific association of steroid hormone pathway gene polymorphisms with breast cancer risk.
    Ralph DA; Zhao LP; Aston CE; Manjeshwar S; Pugh TW; DeFreese DC; Gramling BA; Shimasaki CD; Jupe ER
    Cancer; 2007 May; 109(10):1940-8. PubMed ID: 17436274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comprehensive analysis of the androgen receptor gene and risk of breast cancer: results from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium (BPC3).
    Cox DG; Blanché H; Pearce CL; Calle EE; Colditz GA; Pike MC; Albanes D; Allen NE; Amiano P; Berglund G; Boeing H; Buring J; Burtt N; Canzian F; Chanock S; Clavel-Chapelon F; Feigelson HS; Freedman M; Haiman CA; Hankinson SE; Henderson BE; Hoover R; Hunter DJ; Kaaks R; Kolonel L; Kraft P; LeMarchand L; Lund E; Palli D; Peeters PH; Riboli E; Stram DO; Thun M; Tjonneland A; Trichopoulos D; Yeager M;
    Breast Cancer Res; 2006; 8(5):R54. PubMed ID: 16987421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ERCC4 associated with breast cancer risk: a two-stage case-control study using high-throughput genotyping.
    Milne RL; Ribas G; González-Neira A; Fagerholm R; Salas A; González E; Dopazo J; Nevanlinna H; Robledo M; Benítez J
    Cancer Res; 2006 Oct; 66(19):9420-7. PubMed ID: 17018596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymorphisms in folate metabolizing enzymes and transport proteins and the risk of breast cancer.
    Kotsopoulos J; Zhang WW; Zhang S; McCready D; Trudeau M; Zhang P; Sun P; Narod SA
    Breast Cancer Res Treat; 2008 Dec; 112(3):585-93. PubMed ID: 18204969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nested case-control study of energy regulation candidate gene single nucleotide polymorphisms and breast cancer.
    Wang Y; McCullough ML; Stevens VL; Rodriguez C; Jacobs EJ; Teras LR; Pavluck AL; Thun MJ; Calle EE
    Anticancer Res; 2007; 27(1B):589-93. PubMed ID: 17348446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polymorphisms in three base excision repair genes and breast cancer risk in Thai women.
    Sangrajrang S; Schmezer P; Burkholder I; Waas P; Boffetta P; Brennan P; Bartsch H; Wiangnon S; Popanda O
    Breast Cancer Res Treat; 2008 Sep; 111(2):279-88. PubMed ID: 17922186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.